Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings.
Hear answer to questions such as:
Clinical Professor of Family and Community Medicine
Sidney Kimmel College of Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania
Chair, Department of Family and Community Medicine
Abington-Jefferson Health
Abington, Pennsylvania
Associate Professor of Medicine
Division of General Internal Medicine
Department of Medicine
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Primary Care Physician
Division of General Internal Medicine
Department of Medicine
Denver Health
Denver, Colorado
Professor
Family Medicine
University of Michigan Medical School
Ann Arbor, Michigan
This program has been made available online.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.